Pneumovax 23

Pneumococcal polysaccharide vaccine 23-valent · Merck & Co.

Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for Pneumovax 23, covering 2007-12-27 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma [Phase 4]

See pricing